Risks inherent in fetal gene therapy

descriptionPublicationkeyboard_double_arrow_right Article 04 Feb 1999 English Publisher:Springer Science and Business Media LLCJournal:Nature, volume 397, pages 383-383 (issn: 0028-0836, eissn: 1476-4687,

Copyright policy )

Authors: D, King; T, Shakespeare; R, Nicholson; A, Clarke; S, McLean;

doi: 10.1038/16998

pmid: 9989397

Risks inherent in fetal gene therapy

- Summary
- Subjects
- Metrics

Related Organizations

University of Glasgow
United Kingdom
University of Leeds
United Kingdom
Cardiff and Vale University Health Board
United Kingdom
University Hospital of Wales
United Kingdom

Keywords

Eugenics, Genetic Therapy, Fetal Research, Risk Assessment, United Kingdom, United States, Fetal Diseases, Genetic Enhancement, Germ Cells, Risk Factors, Humans, Severe Combined Immunodeficiency, Genetic Engineering

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	11
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%